Welcome to the new academic journal OBM Hepatology and Gastroenterology. Recent progress in understanding liver, biliary, pancreatic and gastro-intestinal diseases and their treatments has been observed in the world. OBM Hepatology and Gastroenterology publishes interesting and informative reviews, original articles, and invaluable case reports in this area. We also publish basic research as well as clinical research.

Hepatitis A virus (HAV), HBV, HCV, HDV, and HEV are still a serious issue worldwide. Treatments on these viruses have recently improved. However, liver fibrosis, cirrhosis and hepatocellular carcinoma are still critical conditions. We focus on all of these liver diseases. We also focus on broad-spectrum of gastro-intestinal diseases in this journal.

Please accept our special thanks for choosing to publish in the OBM Hepatology and Gastroenterology. We are looking forward to your submissions for OBM Hepatology and Gastroenterology.

Indexing: DOAJ-Directory of Open Access Journals.

Archiving: full-text archived in CLOCKSS.

Free Publication in 2020
Current Issue: 2020  Archive: 2019 2018 2017

Special Issue

Gut Microbiota and Gut Health

Submission Deadline: December 31, 2020 (Open) Submit Now

Guest Editor

Rostyslav Bubnov, MD, PhD, LLM

Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kyiv, Ukraine

Website | E-Mail

Research Interests: Microbiome, Metabolic syndrome, Gut health, Probiotics, Prebiotics, Predictive preventive personalized medicine, Radiology, Ultrasound, Lactobacillus, Bifidobacterium

About this Topic

Gut microbiota (GM) has close interaction with human metabolism and immune system. Gut and distant sites microbiome, directly or indirect mechanisms of impact on gut and metabolic health via interaction with intestinal mucosa and producing metabolites. The issue "Gut Microbiota and Gut Health" covers the novel aspects of gut health associated with microbiome, includes contributions on innovative hypotheses, basic research and clinical trials capable to increase the up to date evidence. Studies of complexity of microbial composition and diversity as a potential diagnostic and predictive biomarker and potential targeted treatments based on modulating mirobiome, namely using probiotics, prebiotics, fecal microbiota transplantation (FMT), dietary interventions and novel treatment approaches which need personalization.